Group 1 - The company announced a profit forecast indicating a return to losses in 2025, with expected net profit attributable to shareholders ranging from -105 million to -84 million yuan [1] - In 2024, the company reported a total profit of 11.83 million yuan, with a net profit attributable to shareholders of 10.25 million yuan, and a net profit excluding non-recurring gains and losses of -3.28 million yuan [1] - The company is undergoing a strategic adjustment due to changes in industry trends and market conditions, which has led to a decline in revenue and gross profit [1] Group 2 - Since its market debut in July 2021, the company's performance has shown significant volatility, with a 24.69% revenue decline in 2022 and a net profit loss of -124 million yuan [2] - Despite a revenue increase of over 40% in 2023, the company still reported a net profit loss of -50.87 million yuan [2] - The company specializes in the research and development of health products, particularly portable smart massagers, and is recognized as a national high-tech enterprise [3] Group 3 - The company and its actual controller are under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure laws [3] - As of January 28, the company's stock price was 22.23 yuan per share, reflecting a decline of 1.98%, with a total market capitalization of 1.911 billion yuan [3]

Group 1 - The core viewpoint of the article highlights that Shenzhen Beilingsong Technology Co., Ltd. anticipates a net profit loss of 84 million to 105 million yuan for the fiscal year 2025, attributed to strategic adjustments and upgrades within the company [1] - The intelligent massage device industry is undergoing a critical period of high-quality transformation, facing intensified competition and evolving consumer demands towards efficacy and experience [1] - The company is focusing on a "Traditional Chinese Medicine × Technology" core strategy, emphasizing technological research and development, global expansion, and innovative business models to strengthen its development foundation [1] Group 2 - On the technology front, the company is concentrating on AI integration to build core competitiveness, upgrading its Traditional Chinese Medicine constitution identification model, and collaborating with major tech firms to enhance user experience and product precision [2] - The company is expanding its sales network in Southeast Asia and the Middle East, with plans to open 10 to 20 new stores in Southeast Asia by 2026, leveraging FDA-certified laser hair care technology to penetrate high-end markets in Europe and the U.S. [2] - The company is innovating its business model by launching the "Easy Moment" brand in 2025, which combines products with massage and moxibustion, and has already established 15 stores in various cities [2] Group 3 - The company is leveraging "Traditional Chinese Medicine × Technology" as a driving force, continuously broadening its growth boundaries and injecting momentum for long-term high-quality development [3]

Core Viewpoint - The company expects a significant decline in net profit for the year 2025, projecting a loss compared to the previous year's profit [1] Financial Projections - The company anticipates a net profit attributable to the parent company of between -105 million to -84 million yuan for 2025, compared to a profit of 10.25 million yuan in the same period last year [1] - The expected net profit attributable to the parent company, excluding non-recurring gains and losses, is projected to be between -92 million to -71 million yuan [1]

北京商报讯（记者 丁宁）1月27日晚间，倍轻松（688793）发布2025年度业绩预告显示，公司2025年预 计实现归属净利润-8400万元至-1.05亿元。 倍轻松表示，公司结合行业发展趋势及市场环境变化对经营战略进行阶段性调整，受战略调整过渡期影 响，报告期内营业收入较上年同期下降，进而带动毛利额下降；同时，经营端销售费用投入产出效能未 达预期，而固定支出和刚性成本短期内无法与营收规模实现同步压降，多重因素叠加下，使得利润总 额、归属净利润、扣非净利润下降。 ...

证券日报网讯1月27日，倍轻松在互动平台回答投资者提问时表示，公司股价波动受市场环境、宏观经 济形势、投资者心理预期等多种因素影响。目前公司各项经营活动和业务均正常开展。 ...

Core Viewpoint - The company, Beikong (688793.SH), announced that it expects to report a net loss attributable to shareholders of the parent company for the fiscal year 2025, with an estimated net profit ranging from -105 million to -84 million yuan compared to the previous year [1] Financial Performance - The projected net profit for 2025 is estimated to be between -105 million yuan and -84 million yuan [1]

Core Viewpoint - The company, Beiliang (688793.SH), anticipates a net profit attributable to shareholders of between -105 million to -84 million yuan for the fiscal year 2025, primarily due to strategic adjustments and upgrades in response to industry changes [1] Group 1: Industry Transition and Company Strategy - The smart massage device industry is undergoing a critical transition towards high-quality development, with intensified competition and evolving consumer demands focusing on efficacy and experience [1] - Beiliang's recent performance fluctuations reflect the objective realities of this industry transition, as the company actively adapts to both industry and operational changes [1] - The company is committed to its core strategy of "Traditional Chinese Medicine × Technology," focusing on technological research and development, global expansion, and innovative business models to enhance quality and efficiency [1] Group 2: AI Integration and Product Development - Beiliang is integrating AI as a core direction in product development, combining traditional wellness wisdom with modern technology [2] - The upgraded Chinese constitution identification model, along with AI analysis modules for tongue and pulse, will enable real-time constitution reports based on data from smart wearable devices [2] - Collaborations with tech giants like Alibaba Cloud and Baidu have led to the successful implementation of technologies that enhance user experience and massage precision [2] Group 3: Global Expansion and Brand Development - The company is advancing its globalization strategy by building a comprehensive sales network that integrates online and offline channels, focusing on Southeast Asia and the Middle East [3] - Plans for 2026 include opening 10-20 new offline stores in Southeast Asia, expanding successful models from Thailand to Indonesia and Vietnam [3] - Participation in international exhibitions, such as CES, showcases new products like the AIR3 smart massager and See7R eye massager, enhancing brand visibility and global market penetration [3] Group 4: Innovative Business Models and Growth Opportunities - Beiliang is launching the "Easy Moment" health management brand in 2025, combining self-developed technology products with manual massage and moxibustion therapy to create a hybrid business model [4] - Strategic partnerships with leading automotive companies like BYD and Chery are being formed to explore health solutions in the automotive sector, opening new growth channels [4] - The company is also addressing the aging population by developing products tailored for elderly users, with 13 products already included in a government initiative for smart home upgrades [4] Group 5: Long-term Development and Market Positioning - Through the integration of "Traditional Chinese Medicine × Technology" and diverse business models, Beiliang is continuously expanding its growth boundaries and strengthening its brand presence in both domestic and international markets [5]

Core Viewpoint - The company, Beilingsong (688793.SH), anticipates a net profit attributable to shareholders of between -105 million and -84 million yuan for the fiscal year 2025, primarily due to strategic adjustments and upgrades [1] Financial Performance - The projected net profit for 2025 is expected to be between -105 million and -84 million yuan, indicating a significant loss [1] Strategic Initiatives - Beilingsong is focusing on a "Traditional Chinese Medicine × Technology" core strategy, increasing investment in research and development and model innovation to lay a foundation for long-term high-quality growth [1] - The company has launched the "Early Sleep Doll" IP product series, which has gained over 100 million exposures on social media platforms, showcasing its marketing effectiveness [1] Marketing and Sales - The company initiated a nationwide tour starting in Shenzhen, which has significantly boosted in-store sales, demonstrating the conversion potential of IP-based marketing [1] - Innovative online and offline marketing strategies have highlighted Beilingsong's strong brand building and market influence in the health and personal care sector [1] Service Ecosystem Development - Beilingsong is upgrading its offline service ecosystem with the introduction of the "Relaxation Moment" health management brand, which combines technology product experiences, manual massage, and traditional moxibustion therapy [1] - The company has rapidly established 15 stores in key cities such as Shenzhen, Guangzhou, and Chengdu, and plans to continue its "product + service" dual-driven development path to strengthen its leading position in the health consumption sector [1]

Group 1 - The company, Beiqing Song, announced an earnings forecast indicating a net loss attributable to shareholders of the parent company for the year 2025, estimated between -105 million yuan and -84 million yuan compared to the previous year [1] - The primary reason for the earnings fluctuation is the company's strategic adjustment in response to industry trends and market environment changes, which has led to a decrease in operating revenue and gross profit compared to the same period last year [1] - Additionally, the company's sales expense efficiency did not meet expectations, while fixed and rigid costs could not be synchronized with revenue scale in the short term, resulting in a decline in total profit, net profit attributable to shareholders, and net profit excluding non-recurring gains and losses [1]

证券代码：688793 证券简称：倍轻松 公告编号：2026-001 深圳市倍轻松科技股份有限公司 2025 年年度业绩预告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、本期业绩预告情况 （一）业绩预告期间 2025 年 1 月 1 日至 2025 年 12 月 31 日。 （二）业绩预告情况 （1）经财务部门初步测算，预计 2025 年年度实现归属于母公司所有者的净 利润与上年同期（法定披露数据）相比，将出现亏损，预计实现归属于母公司所 有者的净利润为 -10,500 万元到 -8,400 万元。 （2）经财务部门初步测算，预计 2025 年归属于母公司所有者扣除非经常性 损益后的净利润为 -9,200 万元到 -7,100 万元。 （三）本次业绩预告未经注册会计师审计。 二、上年同期业绩情况和财务状况 （一）利润总额：1,182.63 万元。归属于母公司所有者的净利润：1,025.32 万元。归属于母公司所有者的扣除非经常性损益的净利润：-327.69 万元。 （二）每股收益：0.12 元。 三、本期业绩变化的主要 ...